Page last updated: 2024-08-26

sugiol and Carcinoma

sugiol has been researched along with Carcinoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Han, DC; Jeon, YJ; Jung, SN; Kang, JS; Kim, HN; Kwon, BM; Lee, YJ; Shin, DS; Yun, J	1

Other Studies

1 other study(ies) available for sugiol and Carcinoma

Article	Year
Sugiol inhibits STAT3 activity via regulation of transketolase and ROS-mediated ERK activation in DU145 prostate carcinoma cells. Biochemical pharmacology, 2015, Sep-01, Volume: 97, Issue:1 Topics: Animals; Antineoplastic Agents, Phytogenic; Carcinoma; Cell Line, Tumor; Diterpenes; Enzyme Activation; Enzyme Inhibitors; Female; Genes, Reporter; Humans; Male; MAP Kinase Signaling System; Mice, Inbred BALB C; Mice, Nude; Neoplasm Proteins; Prostatic Neoplasms; Protein Tyrosine Phosphatases, Non-Receptor; Reactive Oxygen Species; STAT3 Transcription Factor; Transketolase; Tumor Burden; Xenograft Model Antitumor Assays	2015

Article

Year

Sugiol inhibits STAT3 activity via regulation of transketolase and ROS-mediated ERK activation in DU145 prostate carcinoma cells.

Biochemical pharmacology, 2015, Sep-01, Volume: 97, Issue:1

Topics: Animals; Antineoplastic Agents, Phytogenic; Carcinoma; Cell Line, Tumor; Diterpenes; Enzyme Activation; Enzyme Inhibitors; Female; Genes, Reporter; Humans; Male; MAP Kinase Signaling System; Mice, Inbred BALB C; Mice, Nude; Neoplasm Proteins; Prostatic Neoplasms; Protein Tyrosine Phosphatases, Non-Receptor; Reactive Oxygen Species; STAT3 Transcription Factor; Transketolase; Tumor Burden; Xenograft Model Antitumor Assays

2015